TetraScience
$20.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
TetraScience is currently valued at N/A as of January 24, 2025. The company has raised a total of $127.1M in funding.
Investment Perspective
TetraScience's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is TetraScience Worth in 2025?
As of 2025, TetraScience is valued at N/A, based on the company's Mezzanine funding round in January 24, 2025. This valuation positions TetraScience as one of the leading private companies in the sector.
TetraScience Valuation History
TetraScience's funding history demonstrates steady growth and investor confidence.
How TetraScience Valuation is Determined
Private company valuations like TetraScience's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
TetraScience Valuation FAQs
Is TetraScience profitable?
TetraScience has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does TetraScience's valuation compare to competitors?
TetraScience is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will TetraScience IPO?
TetraScience has not announced plans for an initial public offering. Until an IPO, investors can access TetraScience shares through secondary market platforms.